Skip to content

Released Nov 3, 2015, after the close

10-Q filed Nov 3, 2015, 34 days after period end · 0001564590-15-009166

Q3 2015 · 10-Q
Revenue$101.15M+0.2% vs Q3 2014+0.2% vs Q2 2015
Net Income-$1.37MN/M vs Q3 2014N/M vs Q2 2015
EPS Diluted-$0.07N/M vs Q3 2014N/M vs Q2 2015
Gross Profit$77,286,000+2.1%
Operating Income$4,139,000−36.4%
Operating Cash Flowderived$17,585,000−2.8%
Free Cash Flowderived$10,098,000−21.8%
Margins · derived
Gross margin76.4%+1.4 pt vs Q3 2014
Operating margin4.1%−2.4 pt vs Q3 2014
Net margin-1.4%−1.8 pt vs Q3 2014

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ3 2015Q3 2014Q3 2013Q3 2012
Revenue$101.15M$100.99M$91.81M$105.82M
Net Income-$1.37M$452.00K-$18.84M$3.75M
EPS Diluted-$0.07$0.02-$1.04$0.19

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR